FMXIN002 single dose clinical trials

Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis

This study compares a new nasal powder (FMXIN002) to the EpiPen for treating severe allergic reactions. We're testing how the body handles the new medicine and how well it works in healthy adults with hay fever, checking different doses and nasal conditions.